BEGIN:VCALENDAR VERSION:2.0 PRODID:-//ISPE D/A/CH - ECPv6.17.2//NONSGML v1.0//EN CALSCALE:GREGORIAN METHOD:PUBLISH X-ORIGINAL-URL:https://en.ispe-dach.org X-WR-CALDESC:Events for ISPE D/A/CH REFRESH-INTERVAL;VALUE=DURATION:PT1H X-Robots-Tag:noindex X-PUBLISHED-TTL:PT1H BEGIN:VTIMEZONE TZID:Europe/Berlin BEGIN:DAYLIGHT TZOFFSETFROM:+0100 TZOFFSETTO:+0200 TZNAME:CEST DTSTART:20240331T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0200 TZOFFSETTO:+0100 TZNAME:CET DTSTART:20241027T010000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:+0100 TZOFFSETTO:+0200 TZNAME:CEST DTSTART:20250330T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0200 TZOFFSETTO:+0100 TZNAME:CET DTSTART:20251026T010000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:+0100 TZOFFSETTO:+0200 TZNAME:CEST DTSTART:20260329T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0200 TZOFFSETTO:+0100 TZNAME:CET DTSTART:20261025T010000 END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTART;TZID=Europe/Berlin:20251103T080000 DTEND;TZID=Europe/Berlin:20251104T180000 DTSTAMP:20251023T155447Z CREATED:20250624T130517Z LAST-MODIFIED:20251023T155447Z UID:21076-1762156800-1762279200@en.ispe-dach.org SUMMARY:Future Leaders' Days 2025 DESCRIPTION:Collaborations are becoming increasingly important in the healthcare industry to bring complex innovations—such as novel drugs\, medical technology\, or diagnostics—to market more quickly. In this event\, experts from research\, industry\, and regulatory bodies will demonstrate how collaborations pool expertise across the value chain\, shorten product and application development times\, enable faster scaling\, and enhance the security of supply for patients. \n \n \n \n \n \n \n \n \n \n \n \n What can you expect? \n \n \n \n Best practices\, use cases\, and discussions on successful collaboration models across the entire value chain of the healthcare industry.The focus is on proposed solutions to specific key questions and obstacles: Research & Development – Achieving More Together:“How can public-private partnerships accelerate the development of new active ingredients?”“How can long-standing partnerships advance point-of-care diagnostics?”Collaboration in Scaling\, Production\, and Supply Chains: “How can strategic partnerships be used as an alternative to the ‘one-stop shop’ strategy?”“How can new business models be developed collaboratively among research institutions\, startups\, and industry partners?”Time to Market\, Product Lifecycles\, and Regulation:“How can strategic partnerships accelerate and simplify the commercialization of complex biopharmaceuticals for patients?” \n \n \n \n \n \n \n \n Presentations\, discussions\, roundtables\, and networking \n \n \n \n Interdisciplinary exchange with colleagues and technology partners on barriers to innovation\, the opportunities presented by collaborative models for developing new solutions\, and regulatory issues.Why should you take part? Firsthand insight: Experts share their experiences in various areas of the healthcare industry’s value chain.Best Practices: Learn from existing use cases and work with other participants to develop strategic ideas.Strengthen Your Network: Meet leading figures in the biotech industry from the D/A/CH region\, build valuable connections\, and exchange ideas with fellow professionals.Get Involved: Your perspective will be incorporated into a collaborative magazine that brings together the ideas and proposed solutions developed during the process. \n \n \n \n \n \n \n \n \n \n \n \n Organizers and Partners \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n The event is organized by the BioPharma Cluster South Germany and is part of the collaborative project SynergyHub4Health\, which strengthens interregional networking and promotes the transfer of knowledge on forward-looking topics. The Bioregions BioPharma Cluster South Germany e.V.\, BioRegion STERN Management GmbH\, BioLAGO e.V. and bioRN Life Science Cluster\, as well as the German-speaking section of the International Society for Pharmaceutical Engineering (ISPE D/A/CH) and BIOPRO Baden-Württemberg GmbH as associate partners\, are pooling their complementary expertise to drive new innovation and develop solutions to existing challenges in the healthcare industry. The initiative is funded by the state of Baden-Württemberg as part of the European Regional Development Fund (ERDF). \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Key Details \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Target audianceSpecialists and executives from academia and industryTechnology scouts\, process engineers\, innovation managersRegulatory Affairs OfficerEveryone involved in the life sciences value chainDateFebruary 24\, 2027\, 8:30 a.m. – February 25\, 2027\, 5:30 p.m. LocationUlm City HallMünsterplatz 5089073 UlmGermany LanguageGerman. \n \n \n \n \n \n \n \n More information about registration will follow soon URL:https://en.ispe-dach.org/events/future-leaders-days-2025/ LOCATION:Hotel Meliá Vienna\, Donau-City-Straße 7\, Wien\, 1220\, Austria CATEGORIES:Emerging Leaders and Students ATTACH;FMTTYPE=image/jpeg:https://en.ispe-dach.org/wp-content/uploads/2025/06/WhatsApp-Image-2025-10-12-at-16.23.49.jpeg ORGANIZER;CN="ISPE Emerging Leaders":MAILTO:EL@ispe-dach.org END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Berlin:20251114T140000 DTEND;TZID=Europe/Berlin:20251114T170000 DTSTAMP:20250917T044037Z CREATED:20250902T142706Z LAST-MODIFIED:20250917T044037Z UID:21528-1763128800-1763139600@en.ispe-dach.org SUMMARY:ISPE CoP PM meets SIKA DESCRIPTION:Collaborations are becoming increasingly important in the healthcare industry to bring complex innovations—such as novel drugs\, medical technology\, or diagnostics—to market more quickly. In this event\, experts from research\, industry\, and regulatory bodies will demonstrate how collaborations pool expertise across the value chain\, shorten product and application development times\, enable faster scaling\, and enhance the security of supply for patients. \n \n \n \n \n \n \n \n \n \n \n \n What can you expect? \n \n \n \n Best practices\, use cases\, and discussions on successful collaboration models across the entire value chain of the healthcare industry.The focus is on proposed solutions to specific key questions and obstacles: Research & Development – Achieving More Together:“How can public-private partnerships accelerate the development of new active ingredients?”“How can long-standing partnerships advance point-of-care diagnostics?”Collaboration in Scaling\, Production\, and Supply Chains: “How can strategic partnerships be used as an alternative to the ‘one-stop shop’ strategy?”“How can new business models be developed collaboratively among research institutions\, startups\, and industry partners?”Time to Market\, Product Lifecycles\, and Regulation:“How can strategic partnerships accelerate and simplify the commercialization of complex biopharmaceuticals for patients?” \n \n \n \n \n \n \n \n Presentations\, discussions\, roundtables\, and networking \n \n \n \n Interdisciplinary exchange with colleagues and technology partners on barriers to innovation\, the opportunities presented by collaborative models for developing new solutions\, and regulatory issues.Why should you take part? Firsthand insight: Experts share their experiences in various areas of the healthcare industry’s value chain.Best Practices: Learn from existing use cases and work with other participants to develop strategic ideas.Strengthen Your Network: Meet leading figures in the biotech industry from the D/A/CH region\, build valuable connections\, and exchange ideas with fellow professionals.Get Involved: Your perspective will be incorporated into a collaborative magazine that brings together the ideas and proposed solutions developed during the process. \n \n \n \n \n \n \n \n \n \n \n \n Organizers and Partners \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n The event is organized by the BioPharma Cluster South Germany and is part of the collaborative project SynergyHub4Health\, which strengthens interregional networking and promotes the transfer of knowledge on forward-looking topics. The Bioregions BioPharma Cluster South Germany e.V.\, BioRegion STERN Management GmbH\, BioLAGO e.V. and bioRN Life Science Cluster\, as well as the German-speaking section of the International Society for Pharmaceutical Engineering (ISPE D/A/CH) and BIOPRO Baden-Württemberg GmbH as associate partners\, are pooling their complementary expertise to drive new innovation and develop solutions to existing challenges in the healthcare industry. The initiative is funded by the state of Baden-Württemberg as part of the European Regional Development Fund (ERDF). \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Key Details \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Target audianceSpecialists and executives from academia and industryTechnology scouts\, process engineers\, innovation managersRegulatory Affairs OfficerEveryone involved in the life sciences value chainDateFebruary 24\, 2027\, 8:30 a.m. – February 25\, 2027\, 5:30 p.m. LocationUlm City HallMünsterplatz 5089073 UlmGermany LanguageGerman. \n \n \n \n \n \n \n \n More information about registration will follow soon URL:https://en.ispe-dach.org/events/ispe-cop-pm-meets-sika/ LOCATION:Sika Switzerland AG\, Tüffenwies 16\, Zürich\, 8048\, Switzerland CATEGORIES:CoP Project Management ATTACH;FMTTYPE=image/jpeg:https://en.ispe-dach.org/wp-content/uploads/2025/09/Sika-Banner-1.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Berlin:20251118T090000 DTEND;TZID=Europe/Berlin:20251119T160000 DTSTAMP:20251014T012114Z CREATED:20250512T131109Z LAST-MODIFIED:20251014T012114Z UID:20743-1763456400-1763568000@en.ispe-dach.org SUMMARY:Annex 1 in practice in 2025 DESCRIPTION:Collaborations are becoming increasingly important in the healthcare industry to bring complex innovations—such as novel drugs\, medical technology\, or diagnostics—to market more quickly. In this event\, experts from research\, industry\, and regulatory bodies will demonstrate how collaborations pool expertise across the value chain\, shorten product and application development times\, enable faster scaling\, and enhance the security of supply for patients. \n \n \n \n \n \n \n \n \n \n \n \n What can you expect? \n \n \n \n Best practices\, use cases\, and discussions on successful collaboration models across the entire value chain of the healthcare industry.The focus is on proposed solutions to specific key questions and obstacles: Research & Development – Achieving More Together:“How can public-private partnerships accelerate the development of new active ingredients?”“How can long-standing partnerships advance point-of-care diagnostics?”Collaboration in Scaling\, Production\, and Supply Chains: “How can strategic partnerships be used as an alternative to the ‘one-stop shop’ strategy?”“How can new business models be developed collaboratively among research institutions\, startups\, and industry partners?”Time to Market\, Product Lifecycles\, and Regulation:“How can strategic partnerships accelerate and simplify the commercialization of complex biopharmaceuticals for patients?” \n \n \n \n \n \n \n \n Presentations\, discussions\, roundtables\, and networking \n \n \n \n Interdisciplinary exchange with colleagues and technology partners on barriers to innovation\, the opportunities presented by collaborative models for developing new solutions\, and regulatory issues.Why should you take part? Firsthand insight: Experts share their experiences in various areas of the healthcare industry’s value chain.Best Practices: Learn from existing use cases and work with other participants to develop strategic ideas.Strengthen Your Network: Meet leading figures in the biotech industry from the D/A/CH region\, build valuable connections\, and exchange ideas with fellow professionals.Get Involved: Your perspective will be incorporated into a collaborative magazine that brings together the ideas and proposed solutions developed during the process. \n \n \n \n \n \n \n \n \n \n \n \n Organizers and Partners \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n The event is organized by the BioPharma Cluster South Germany and is part of the collaborative project SynergyHub4Health\, which strengthens interregional networking and promotes the transfer of knowledge on forward-looking topics. The Bioregions BioPharma Cluster South Germany e.V.\, BioRegion STERN Management GmbH\, BioLAGO e.V. and bioRN Life Science Cluster\, as well as the German-speaking section of the International Society for Pharmaceutical Engineering (ISPE D/A/CH) and BIOPRO Baden-Württemberg GmbH as associate partners\, are pooling their complementary expertise to drive new innovation and develop solutions to existing challenges in the healthcare industry. The initiative is funded by the state of Baden-Württemberg as part of the European Regional Development Fund (ERDF). \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Key Details \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Target audianceSpecialists and executives from academia and industryTechnology scouts\, process engineers\, innovation managersRegulatory Affairs OfficerEveryone involved in the life sciences value chainDateFebruary 24\, 2027\, 8:30 a.m. – February 25\, 2027\, 5:30 p.m. LocationUlm City HallMünsterplatz 5089073 UlmGermany LanguageGerman. \n \n \n \n \n \n \n \n More information about registration will follow soon URL:https://en.ispe-dach.org/events/annex-1-in-practice-in-2025/ LOCATION:Takeda Linz\, St.-Peter-Strasse 25\, Linz\, 4020\, Austria CATEGORIES:CoP Aseptic ATTACH;FMTTYPE=image/png:https://en.ispe-dach.org/wp-content/uploads/2024/11/ISPE-DACH-Banner-neu.png ORGANIZER;CN="ISPE CoP Aseptic Processing":MAILTO:volker.storn@ispe-dach.org END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Berlin:20251120T090000 DTEND;TZID=Europe/Berlin:20251120T180000 DTSTAMP:20251114T044656Z CREATED:20250902T150702Z LAST-MODIFIED:20251114T044656Z UID:21543-1763629200-1763661600@en.ispe-dach.org SUMMARY:Industry meets Women in Pharma sponsored by Merck: Building the Future - Inclusive. Innovative. Impactful. DESCRIPTION:Collaborations are becoming increasingly important in the healthcare industry to bring complex innovations—such as novel drugs\, medical technology\, or diagnostics—to market more quickly. In this event\, experts from research\, industry\, and regulatory bodies will demonstrate how collaborations pool expertise across the value chain\, shorten product and application development times\, enable faster scaling\, and enhance the security of supply for patients. \n \n \n \n \n \n \n \n \n \n \n \n What can you expect? \n \n \n \n Best practices\, use cases\, and discussions on successful collaboration models across the entire value chain of the healthcare industry.The focus is on proposed solutions to specific key questions and obstacles: Research & Development – Achieving More Together:“How can public-private partnerships accelerate the development of new active ingredients?”“How can long-standing partnerships advance point-of-care diagnostics?”Collaboration in Scaling\, Production\, and Supply Chains: “How can strategic partnerships be used as an alternative to the ‘one-stop shop’ strategy?”“How can new business models be developed collaboratively among research institutions\, startups\, and industry partners?”Time to Market\, Product Lifecycles\, and Regulation:“How can strategic partnerships accelerate and simplify the commercialization of complex biopharmaceuticals for patients?” \n \n \n \n \n \n \n \n Presentations\, discussions\, roundtables\, and networking \n \n \n \n Interdisciplinary exchange with colleagues and technology partners on barriers to innovation\, the opportunities presented by collaborative models for developing new solutions\, and regulatory issues.Why should you take part? Firsthand insight: Experts share their experiences in various areas of the healthcare industry’s value chain.Best Practices: Learn from existing use cases and work with other participants to develop strategic ideas.Strengthen Your Network: Meet leading figures in the biotech industry from the D/A/CH region\, build valuable connections\, and exchange ideas with fellow professionals.Get Involved: Your perspective will be incorporated into a collaborative magazine that brings together the ideas and proposed solutions developed during the process. \n \n \n \n \n \n \n \n \n \n \n \n Organizers and Partners \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n The event is organized by the BioPharma Cluster South Germany and is part of the collaborative project SynergyHub4Health\, which strengthens interregional networking and promotes the transfer of knowledge on forward-looking topics. The Bioregions BioPharma Cluster South Germany e.V.\, BioRegion STERN Management GmbH\, BioLAGO e.V. and bioRN Life Science Cluster\, as well as the German-speaking section of the International Society for Pharmaceutical Engineering (ISPE D/A/CH) and BIOPRO Baden-Württemberg GmbH as associate partners\, are pooling their complementary expertise to drive new innovation and develop solutions to existing challenges in the healthcare industry. The initiative is funded by the state of Baden-Württemberg as part of the European Regional Development Fund (ERDF). \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Key Details \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Target audianceSpecialists and executives from academia and industryTechnology scouts\, process engineers\, innovation managersRegulatory Affairs OfficerEveryone involved in the life sciences value chainDateFebruary 24\, 2027\, 8:30 a.m. – February 25\, 2027\, 5:30 p.m. LocationUlm City HallMünsterplatz 5089073 UlmGermany LanguageGerman. \n \n \n \n \n \n \n \n More information about registration will follow soon URL:https://en.ispe-dach.org/events/industry-meets-women-in-pharma-sponsored-by-merck/ LOCATION:Merck Darmstadt\, Frakfurter Str. 250\, Darmstadt\, Germany CATEGORIES:WIP,Women in Pharma ATTACH;FMTTYPE=image/png:https://en.ispe-dach.org/wp-content/uploads/2025/02/00_Industry-meets-WiP-Banner_Eveeno.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Berlin:20251125T180000 DTEND;TZID=Europe/Berlin:20251125T200000 DTSTAMP:20251029T130239Z CREATED:20251029T123421Z LAST-MODIFIED:20251029T130239Z UID:22204-1764093600-1764100800@en.ispe-dach.org SUMMARY:Tech Tuesday @SKAN DESCRIPTION:Collaborations are becoming increasingly important in the healthcare industry to bring complex innovations—such as novel drugs\, medical technology\, or diagnostics—to market more quickly. In this event\, experts from research\, industry\, and regulatory bodies will demonstrate how collaborations pool expertise across the value chain\, shorten product and application development times\, enable faster scaling\, and enhance the security of supply for patients. \n \n \n \n \n \n \n \n \n \n \n \n What can you expect? \n \n \n \n Best practices\, use cases\, and discussions on successful collaboration models across the entire value chain of the healthcare industry.The focus is on proposed solutions to specific key questions and obstacles: Research & Development – Achieving More Together:“How can public-private partnerships accelerate the development of new active ingredients?”“How can long-standing partnerships advance point-of-care diagnostics?”Collaboration in Scaling\, Production\, and Supply Chains: “How can strategic partnerships be used as an alternative to the ‘one-stop shop’ strategy?”“How can new business models be developed collaboratively among research institutions\, startups\, and industry partners?”Time to Market\, Product Lifecycles\, and Regulation:“How can strategic partnerships accelerate and simplify the commercialization of complex biopharmaceuticals for patients?” \n \n \n \n \n \n \n \n Presentations\, discussions\, roundtables\, and networking \n \n \n \n Interdisciplinary exchange with colleagues and technology partners on barriers to innovation\, the opportunities presented by collaborative models for developing new solutions\, and regulatory issues.Why should you take part? Firsthand insight: Experts share their experiences in various areas of the healthcare industry’s value chain.Best Practices: Learn from existing use cases and work with other participants to develop strategic ideas.Strengthen Your Network: Meet leading figures in the biotech industry from the D/A/CH region\, build valuable connections\, and exchange ideas with fellow professionals.Get Involved: Your perspective will be incorporated into a collaborative magazine that brings together the ideas and proposed solutions developed during the process. \n \n \n \n \n \n \n \n \n \n \n \n Organizers and Partners \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n The event is organized by the BioPharma Cluster South Germany and is part of the collaborative project SynergyHub4Health\, which strengthens interregional networking and promotes the transfer of knowledge on forward-looking topics. The Bioregions BioPharma Cluster South Germany e.V.\, BioRegion STERN Management GmbH\, BioLAGO e.V. and bioRN Life Science Cluster\, as well as the German-speaking section of the International Society for Pharmaceutical Engineering (ISPE D/A/CH) and BIOPRO Baden-Württemberg GmbH as associate partners\, are pooling their complementary expertise to drive new innovation and develop solutions to existing challenges in the healthcare industry. The initiative is funded by the state of Baden-Württemberg as part of the European Regional Development Fund (ERDF). \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Key Details \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Target audianceSpecialists and executives from academia and industryTechnology scouts\, process engineers\, innovation managersRegulatory Affairs OfficerEveryone involved in the life sciences value chainDateFebruary 24\, 2027\, 8:30 a.m. – February 25\, 2027\, 5:30 p.m. LocationUlm City HallMünsterplatz 5089073 UlmGermany LanguageGerman. \n \n \n \n \n \n \n \n More information about registration will follow soon URL:https://en.ispe-dach.org/events/tech-tuesday-skan/ LOCATION:SKAN AG\, Kreuzstrasse 5\, Allschwil\, 4123 CATEGORIES:CoP Project Management ATTACH;FMTTYPE=image/png:https://en.ispe-dach.org/wp-content/uploads/2024/11/ISPE-DACH-Banner-neu.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Berlin:20251126T083000 DTEND;TZID=Europe/Berlin:20251127T160000 DTSTAMP:20251125T145102Z CREATED:20250508T122650Z LAST-MODIFIED:20251125T145102Z UID:20723-1764145800-1764259200@en.ispe-dach.org SUMMARY:The Future of Pharmaceutical Water - Next-Gen Purity Inspired by Semiconductor Solutions DESCRIPTION:Collaborations are becoming increasingly important in the healthcare industry to bring complex innovations—such as novel drugs\, medical technology\, or diagnostics—to market more quickly. In this event\, experts from research\, industry\, and regulatory bodies will demonstrate how collaborations pool expertise across the value chain\, shorten product and application development times\, enable faster scaling\, and enhance the security of supply for patients. \n \n \n \n \n \n \n \n \n \n \n \n What can you expect? \n \n \n \n Best practices\, use cases\, and discussions on successful collaboration models across the entire value chain of the healthcare industry.The focus is on proposed solutions to specific key questions and obstacles: Research & Development – Achieving More Together:“How can public-private partnerships accelerate the development of new active ingredients?”“How can long-standing partnerships advance point-of-care diagnostics?”Collaboration in Scaling\, Production\, and Supply Chains: “How can strategic partnerships be used as an alternative to the ‘one-stop shop’ strategy?”“How can new business models be developed collaboratively among research institutions\, startups\, and industry partners?”Time to Market\, Product Lifecycles\, and Regulation:“How can strategic partnerships accelerate and simplify the commercialization of complex biopharmaceuticals for patients?” \n \n \n \n \n \n \n \n Presentations\, discussions\, roundtables\, and networking \n \n \n \n Interdisciplinary exchange with colleagues and technology partners on barriers to innovation\, the opportunities presented by collaborative models for developing new solutions\, and regulatory issues.Why should you take part? Firsthand insight: Experts share their experiences in various areas of the healthcare industry’s value chain.Best Practices: Learn from existing use cases and work with other participants to develop strategic ideas.Strengthen Your Network: Meet leading figures in the biotech industry from the D/A/CH region\, build valuable connections\, and exchange ideas with fellow professionals.Get Involved: Your perspective will be incorporated into a collaborative magazine that brings together the ideas and proposed solutions developed during the process. \n \n \n \n \n \n \n \n \n \n \n \n Organizers and Partners \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n The event is organized by the BioPharma Cluster South Germany and is part of the collaborative project SynergyHub4Health\, which strengthens interregional networking and promotes the transfer of knowledge on forward-looking topics. The Bioregions BioPharma Cluster South Germany e.V.\, BioRegion STERN Management GmbH\, BioLAGO e.V. and bioRN Life Science Cluster\, as well as the German-speaking section of the International Society for Pharmaceutical Engineering (ISPE D/A/CH) and BIOPRO Baden-Württemberg GmbH as associate partners\, are pooling their complementary expertise to drive new innovation and develop solutions to existing challenges in the healthcare industry. The initiative is funded by the state of Baden-Württemberg as part of the European Regional Development Fund (ERDF). \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Key Details \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Target audianceSpecialists and executives from academia and industryTechnology scouts\, process engineers\, innovation managersRegulatory Affairs OfficerEveryone involved in the life sciences value chainDateFebruary 24\, 2027\, 8:30 a.m. – February 25\, 2027\, 5:30 p.m. LocationUlm City HallMünsterplatz 5089073 UlmGermany LanguageGerman. \n \n \n \n \n \n \n \n More information about registration will follow soon URL:https://en.ispe-dach.org/events/the-future-of-pharmaceutical-water-next-gen-purity-inspired-by-semiconductor-solutions/ LOCATION:mighty Twice Hotel Dresden\, Königsbrücker Str. 121A\, Dresden\, 101099\, Germany CATEGORIES:CoP Critical Utilities ATTACH;FMTTYPE=image/png:https://en.ispe-dach.org/wp-content/uploads/2024/11/ISPE-DACH-Banner-neu.png END:VEVENT END:VCALENDAR